🔗 Share this article

The prestigious award in Physiology or Medicine has been granted for transformative findings that clarify how the immune system targets dangerous infections while sparing the body's own cells.

A trio of renowned scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning immune cells capable of harming the organism.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

The winners will divide a monetary award worth 11m Swedish kronor.

Crucial Findings

"Their work has been decisive for comprehending how the immune system functions and the reason we do not all develop serious autoimmune diseases," stated the head of the award panel.

The team's studies explain a fundamental mystery: How does the defense system defend us from countless infections while keeping our healthy cells intact?

Our body's protection system employs immune cells that scan for signs of disease, even viruses and germs it has not met before.

These defenders utilize detectors—known as recognition units—that are produced randomly in a vast number of combinations.

That provides the immune system the capacity to combat a wide array of threats, but the unpredictability of the mechanism unavoidably creates white blood cells that may target the body.

Protectors of the Immune System

Researchers earlier knew that some of these harmful white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's award recognizes the discovery of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize other immune cells that attack the healthy cells.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

A Nobel panel added, "These findings have laid the foundation for a new field of research and spurred the creation of innovative treatments, for example for tumors and autoimmune diseases."

In malignancies, T-regs prevent the body from fighting the tumor, so studies are focused on reducing their quantity.

For self-attack disorders, experiments are testing increasing regulatory T-cells so the organism is not under attack. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Innovative Studies

Professor Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland removed, leading to autoimmune disease.

He showed that injecting defense cells from healthy mice could prevent the disease—implying there was a mechanism for blocking immune cells from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in mice and humans that resulted in the discovery of a gene critical for how T-regs operate.

"Their groundbreaking research has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a leading physiology specialist.

"This work is a remarkable illustration of how fundamental physiological study can have far-reaching consequences for human health."